[Clinical evaluation of ceftriaxone in the field of gynecology].
Ceftriaxone (Ro 13-9904, CTRX) was administered to 3 cases with gynecological infections and following results were obtained. CTRX was administered by intravenous drip infusion or intravenous injection with 2 g per day for 4 to 6 days. The clinical efficacy was good in all cases (2 cases with pyometra, 1 case with adnexitis and endometritis). No side effect could be determined in all cases.
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002439:Cefotaxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002443:Ceftriaxone; D004716:Endometritis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008875:Middle Aged; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*; D013492:Suppuration / Q000188:drug therapy; D014591:Uterine Diseases / Q000188:drug therapy*
D002443:Ceftriaxone; D002439:Cefotaxime